P3 Health Partners Q3 2026 adjusted EBITDA swings to positive $20.87 million

• P3 Health Partners swung to third-quarter 2026 adjusted EBITDA of $20.87 million from a year-earlier loss of $45.91 million.
• At-risk membership fell 9% year over year to approximately 105,000, reflecting intentional network and payer rationalization.
• FY26 adjusted EBITDA guidance rose to $90 million–$110 million, with a higher midpoint of $100 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. P3 Health Partners Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202611091605BIZWIRE_USPR_____20261109_BW023607) on November 09, 2026, and is solely responsible for the information contained therein.